TAMPA, Fla. — With Canadian legalization of cannabis now a strong likelihood, Neutra Corp.(OTCQB:NTRR) is working to expand distribution of its pesticide-free growing solutions in what could soon be the largest regulated cannabis market in the world.
A new Forum Research poll recently found that a regulated cannabis industry in Canada would have between six and seven million potential customers—about one-third of the nation’s adult population. The survey found that 18 percent of the 1,256 respondents used cannabis in the past year, and that another 13 percent would if the plant was already legal. That adds up to a projected total of 31 percent of Canada’s adult population interested in cannabis products, with some industry analysts forecasting that the total possible market for cannabis in Canada could top $5 billion.
That kind of demand will require a large amount of cannabis crops to satisfy, and NTRR is working to help ensure consumers have access to top-quality plants grown without the use of harsh chemicals unfit for consumption. Alongside its joint venture partner, Surface to Air Solutions (S2O2), NTRR is offering cannabis growers and other businesses a suite of horticultural technologies designed to reduce or eliminate the industry’s reliance upon pesticides to produce healthy crops. NTRR completed a successful case study on some of its horticultural products earlier this year in Colorado, and the products are currently in use in growing facilities in the U.S. and Canada.
“With legalization now all but certain in Canada, the country appears poised to become the largest regulated cannabis market to open yet,” said NTRR CEO Chris Brown. “We were already making efforts to expand our sales into Canada before the election, but now the country is rapidly becoming a top priority for us.”
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Chris Brown, 813-367-2041
President and CEO